Development of First-In-Class Antibody Therapeutics and New Acquisition Brings Hope to Patients with Fibrotic...
The breakthrough discovery of investigational therapies for multiple human diseases by a team of Singapore...
Velabs Therapeutics Receives Exclusive Licence from Alytas Therapeutics for the Development of Therapeutic Antibodies...
Velabs Therapeutics GmbH, a biotech company focused on the rapid screening of functional therapeutic antibodies...
BeiGene obtains certain rights for Leap Therapeutics cancer drug
Chinese biopharmaceutical firm BeiGene has agreed to exclusive rights to develop and commercialise Leap Therapeutics’...
Arena Pharmaceuticals and Beacon Discovery Expand Strategic Relationship Focusing on Multiple Immune and Inflammatory...
Arena Pharmaceuticals, Inc. and Beacon Discovery announced that they entered into a strategic multi-year partnership...
Vaccitech partners with CRUK on NSCLC immunotherapeutic vaccine
Vaccitech has signed a partnership with Cancer Research UK (CRUK) to clinically advance VTP-600, the...
Aptar Pharma to Highlight Drug Delivery Solutions Portfolio and Expanded Services Offering at Pharmapack...
Aptar Pharma, a global leader in drug delivery systems and active packaging solutions, announces that...
Novartis and Forendo enter into tissue hormone focused licensing collaboration
Finland-based Forendo Pharma has announced it has signed a licensing and collaboration agreement with Novartis.
The...
MedPharm moves into $4M expansion of its North Carolina facility
MedPharm, the leader in topical and transdermal drug delivery, has moved into its newly expanded...
Twist Bioscience and Pandion Therapeutics Expand Antibody Optimization Collaboration
Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic...
PCI Pharma Services Announces Major Investment to Expand Development and Manufacturing Capabilities at Tredegar,...
PCI Pharma Services (PCI), a leading pharmaceutical and biopharmaceutical global outsourcing solutions provider, announced it...